Advertisement

A randomized trial of mailed HPV self-sampling for cervical cancer screening among ethnic minority women in South Florida

  • Erin Kobetz
  • Julia Seay
  • Tulay Koru-Sengul
  • Jordan Baeker Bispo
  • Dinah Trevil
  • Martha Gonzalez
  • Andrew Brickman
  • Olveen Carrasquillo
Original Paper
  • 3 Downloads

Abstract

Purpose

HPV self-sampling has previously been shown to increase cervical cancer screening among ethnic minority and immigrant women. We conducted a randomized pragmatic trial to examine the effectiveness of HPV self-sampling delivered via in-person versus by US mail for medically underserved Hispanic, Haitian, and non-Hispanic Black women living in South Florida.

Methods

We randomized women aged 30–65 who had not completed Pap smear screening in the past 3 years into two groups: (1) HPV self-sampling delivered in-person (IP) by a community health worker (CHW; IP + SS) or (2) HPV self-sampling delivered via US mail (SS + Mail). Our primary outcome was HPV self-sampling completion by 6-month post-study enrollment.

Results

We enrolled 600 women. Approximately 65% were Hispanic and 35% were Haitian or non-Hispanic Black. Nearly half (43%) had an income of less than $20,000/year and 67% were uninsured. In intent-to-treat analyses, 71.6% of participants in the SS + Mail group and 81.0% of participants in the IP + SS group completed HPV self-sampling.

Conclusion

Mailed HPV self-sampling is an effective strategy to increase cervical cancer screening among underserved immigrant and ethnic minority women.

Keywords

Cervical cancer screening HPV Immigrant Women Self-sampling 

Notes

Acknowledgments

We wish to thank our study team who played a critical role in ensuring completion of the study. These include our Community Health Workers, Valentine Cesar (Center for Haitian Studies), Maria Azqueta (Citrus Health Inc.), and Linabell Lopez (Community Health Inc.), our Health Choice Network (HCN) Project Manager, Ludmilla Paul, as well as, our data managers Carmen Linarte and Feng Miao.

Funding

This work was supported by the National Cancer Institute (1R01CA183612).

Compliance with ethical standards

Conflict of interest

The authors have no potential conflict of interest to disclose.

Ethical approval

All procedures performed in our study were in accordance with the ethical standards of our institutional review board and with the 1964 Helsinki declaration and its later amendments.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    U.S. Cancer Statistics Working Group (2016) United States Cancer Statistics: 1999–2013 incidence and mortality web-based report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. http://www.cdc.gov/uscs. Accessed 12 Jan 2017
  2. 2.
    Beavis AL, Gravitt PE, Rositch AF (2017) Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States. Cancer 123:1044–1050CrossRefPubMedGoogle Scholar
  3. 3.
    Musselwhite W, Oliveira CM, Kwaramba T et al (2016) Racial/ethnic disparities in cervical cancer screening and outcomes. Acta Cytol 60:518–526CrossRefPubMedGoogle Scholar
  4. 4.
    Lin L, Benard VB, Greek A, Hawkins NA, Roland KB, Saraiya M (2015) Racial and ethnic differences in human papillomavirus positivity and risk factors among low-income women in Federally Qualified Health Centers in the United States. Prev Med 81:258–261CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Downs LS, Smith JS, Scarinci I, Flowers L, Parham G (2008) The disparity of cervical cancer in diverse populations. Gynecol Oncol 109:S22–S30CrossRefPubMedGoogle Scholar
  6. 6.
    Seay JS, Carrasquillo O, Campos NG, McCann S, Amofah A, Pierre L et al (2015) Cancer screening utilization among immigrant women in Miami, Florida. Prog Commun Health Partnersh Res Educ Action 9(Suppl 2):11–20CrossRefGoogle Scholar
  7. 7.
    Florida Cancer Data System (2014) http://fcds.med.miami.edu/inc/welcome.shtml. Accessed 26 June 2017
  8. 8.
    Centers for Disease Control and Prevention. National Program of Cancer Registries (NPCR). http://www.cdc.gov/cancer/npcr/tools.htm. Accessed 26 June 2017
  9. 9.
    Menard J, Kobetz E, Maldonado JC, Barton B, Blanco J, Diem J (2010) Barriers to cervical cancer screening among Haitian immigrant women in Little Haiti, Miami. J Cancer Educ 25(4):602–608CrossRefPubMedGoogle Scholar
  10. 10.
    Racey CS, Withrow DR, Gesink D (2013) Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis. Can J Public Health 104:e159–e166PubMedGoogle Scholar
  11. 11.
    Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJ, Arbyn M (2015) Reaching women who do not participate in the regular cervical cancer screening program by offering self-sampling kits: a systematic review and meta-analysis of randomized trials. Eur J Cancer 51:2375–2385CrossRefPubMedGoogle Scholar
  12. 12.
    Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L et al (2014) Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 15(2):172–183CrossRefPubMedGoogle Scholar
  13. 13.
    Belinson JL, Du H, Yang B, Wu R, Belinson SE, Qu X et al (2012) Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing. Int J Cancer 130(8):1855–1860CrossRefPubMedGoogle Scholar
  14. 14.
    Huh WK, Ault KA, Chelmow D et al (2015) Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol. https://doi.org/10.1016/j.ygyno.2014.12.022
  15. 15.
    Carrasquillo O, McCann S, Amofah A et al (2014) Rationale and design of the research project of the South Florida Center for the reduction of cancer health disparities (SUCCESS): study protocol for a randomized controlled trial. Trials 15:299CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Carrasquillo O, Seay J, Amofah A et al (2018) HPV self-sampling for cervical cancer screening among ethnic minority women in South Florida: a randomized trial. J General Internal Med.  https://doi.org/10.1007/s11606-018-4404-z Google Scholar
  17. 17.
    Kobetz E, Seay J, Amofah A et al (2017) Mailed HPV self-sampling for cervical cancer screening among underserved minority women: study protocol for a randomized controlled trial. Trials 18(1):19CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Tiro JA, Meissner HI, Kobrin S, Chollette V (2007) What do women in the U.S. know about human papillomavirus (HPV) and cervical cancer? Cancer Epidemiol Biomark Prevent 16(2):288–294CrossRefGoogle Scholar
  19. 19.
    Obama B (January 12th 2017) Statement by the President on Cuban Immigration Policy. The White House. Retrieved 26 June 2017. https://obamawhitehouse.archives.gov/the-press-office/2017/01/12/statement-president-cuban-immigration-policy

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Erin Kobetz
    • 1
    • 2
    • 5
  • Julia Seay
    • 1
    • 2
  • Tulay Koru-Sengul
    • 2
    • 3
  • Jordan Baeker Bispo
    • 3
  • Dinah Trevil
    • 2
  • Martha Gonzalez
    • 2
  • Andrew Brickman
    • 4
  • Olveen Carrasquillo
    • 1
    • 2
  1. 1.Department of MedicineUniversity of Miami Miller School of MedicineMiami-DadeUSA
  2. 2.Sylvester Comprehensive Cancer CenterUniversity of Miami Miller School of MedicineMiami-DadeUSA
  3. 3.Department of Public Health SciencesUniversity of Miami Miller School of MedicineMiami-DadeUSA
  4. 4.The Health Choice NetworkMiami-DadeUSA
  5. 5.University of Miami Miller School of MedicineMiamiUSA

Personalised recommendations